Veeva Systems reported a solid QQ4 2025 with revenue of USD 720.9 million, up 14.31% year-over-year and 3.10% quarter-over-quarter, underscoring continued demand for cloud-based life sciences software. The company delivered strong profitability, with gross margin of 74.9%, operating margin of 26.1%, and net margin of 27.1%. Net income of USD 195.6 million and diluted earnings per share of USD 1.18 reflect disciplined cost management alongside robust top-line growth. Cash generation remained meaningful, as free cash flow reached USD 64.8 million and net operating cash flow was USD 69.5 million, supporting a healthy balance sheet characterized by a substantial net cash position. The balance sheet shows USD 5.15 billion in cash and short-term investments against minimum debt, driving a net debt position of negative USD 1.043 billion and a robust liquidity runway.